That review catches medication interactions, underlying conditions, and dosing issues that a nurse-only or standing-order model will miss
Lactobacillus intestinalis primes epithelial cells to suppress colitis-related Th17 response by host-microbe retinoic acid biosynthesis
Trends and outcomes associated with bariatric surgery and pharmacotherapies with weight loss effects among patients with heart failure and obesity
PlexusDx starts patients at 0.25mg weekly, increasing by 0.25mg every week until reaching the therapeutic maintenance dose of 1mg weekly
CLINICAL Review: The role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: Clinical implications
To completely understand the role of inflammation modulation in the therapeutic benefits of this significant drug class, future research should concentrate on comparing the efficacy of particular agents, conducting mechanistic studies that distinguish direct from indirect effects, and integrating biomarker analyses into clinical outcome trials